Results 101 to 110 of about 3,055,534 (337)
Molecular Oncology, EarlyView.This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
JMIR Medical InformaticsBackgroundAdvances in genetics have underscored a strong association between genetic factors and health outcomes, leading to an increased demand for genetic counseling services.
Takuya Fukushima +9 more
doaj +1 more source
Genetic Counseling in Renal Masses
Advances in Urology, 2008 All urologists have faced patients suffering a renal cancer asking for the occurrence of the disease in their offspring and very often the answer to this question has not been well founded from the scientific point of view, and only in few cases a ...
José Antonio López-Guerrero +3 more
doaj +1 more source
B.M.A. Scientific Meeting, Leicester: Symposia on Medicine and Engineering, Genetic Counselling, Parkinson's Disease, Radioisotopes, and Ultrasonics [PDF]
, 1971 openalex +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Genetic Counselling in X-Linked Eye Diseases [PDF]
, 1973 J. François +3 more
openalex +1 more source
Molecular Oncology, EarlyView.This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga +8 more
wiley +1 more source
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2019 Introduction As the number of Alzheimer's disease (AD) prevention studies grows, many individuals will need to learn their genetic and/or biomarker risk for the disease to determine trial eligibility.
Carolyn M. Langlois +10 more
doaj +1 more source
Genetic Counseling, Papers by Motulsky A.G. , Carter C.O. , A. Emery E.H. et al. MSS Information Corporation, New York 1974. Hard cover, 16 × 23 cm, 256 pp, illustrated. Price: US $ 19.50. [PDF]
, 1975 openalex +1 more source